MedTrace Logo

ThrombX Retriever for Acute Ischemic Stroke Trial

NCT05270122 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-03-28

No results posted yet for this study

Summary

This trial is designed to assess the safety and effectiveness of the ThrombX Retriever.

Conditions

Interventions

DEVICE

Mechanical thrombectomy with ThrombX Retriever

Revascularization

Sponsors & Collaborators

  • ThrombX Medical

    lead INDUSTRY

Principal Investigators

  • Mahesh Jayaraman, MD · Rhode Island Hospital

  • Raul Nogueira, MD, MD · University of Pittsburgh Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2024-04-30
Completion
2024-07-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05270122 on ClinicalTrials.gov